麻豆传媒

The selected newsroom has been added to your list of favorites. Go to My Favorites
Lawrenceville, NJ USA

Our 麻豆传媒 on 麻豆传媒
View All >

麻豆传媒: 672a6e4ed4c2c_ViHCoverNo-ToC2019-03.jpg

ISPOR Releases Emerging Good Practices Guidance on Quantifying Specialized Knowledge in Healthcare

ISPOR announced the publication of an ISPOR Good Practices Report that identifies existing structured expert elicitation protocols that can support healthcare decision making and provides important insights on how to choose which protocols may be...
6-Nov-2024 4:05 AM EST Add to Favorites

麻豆传媒: 67056f2cc5fd9_HEOR-Awards-2024Image150x200.jpg

ISPOR Announces 2024 Health Economics and Outcomes Research Award Honorees

ISPOR鈥擳he Professional Society for Health Economics and Outcomes Research announced today the recipients of its 2024 Health Economics and Outcomes Research (HEOR) Scientific and Leadership Awards.
14-Oct-2024 4:05 AM EDT Add to Favorites

麻豆传媒: 66fafb1e7cc93_ViHCoverNo-ToC2019-03.jpg

Cracking the Code on Medicare's Drug Price Negotiations

ISPOR announced the publication of a study that provides estimates of how the Centers for Medicare & Medicaid Services (CMS) may have determined initial price offers for the first 10 drugs selected for Medicare price negotiation.
1-Oct-2024 4:05 AM EDT Add to Favorites

麻豆传媒: 66f0b478533ad_000Europe-ISPOR2024150x200.jpg

ISPOR Europe 2024 Plenaries and Speakers Announced

ISPOR鈥擳he Professional Society for Health Economics and Outcomes Research announced the plenary sessions and speakers for ISPOR Europe 2024. The conference is the leading European conference for health economics and outcomes research (HEOR) and is...
23-Sep-2024 4:05 AM EDT Add to Favorites

麻豆传媒: 669916c36e5b1_ISPOR-Strat-Plan-2030150x200NW-SF.jpg

ISPOR Announces New Strategic Plan 2030

ISPOR鈥擳he Professional Society for Health Economics and Outcomes Research announced its new Strategic Plan 2030 that presents a bold new vision for the Society and the field of health economics and outcomes research (HEOR).
29-Jul-2024 4:05 AM EDT Add to Favorites

麻豆传媒: 668c3974664c6_ViHCoverNo-ToC2019-03.jpg

Measuring What Matters: Broadening the Scope of Health Economics Evaluation to Incorporate Well-Being

ISPOR鈥擳he Professional Society for Health Economics and Outcomes Research announced the publication of a special themed section of research papers in Value in Health that offer insights into facets of economic evaluation aimed to incorporate...
9-Jul-2024 4:05 AM EDT Add to Favorites

麻豆传媒: 666c8d4306ab3_ViHCoverNo-ToC2019-03.jpg

Confronting the Backlash Against QALYs: Key Insights From Leading Health Economists

ISPOR announced the publication of a collection of papers that examine the long-standing debate surrounding the use of quality-adjusted life years (QALYs) and alternative measures in healthcare decision making.
18-Jun-2024 4:05 AM EDT Add to Favorites

麻豆传媒: 666c6fad404a6_ViHCoverNo-ToC2019-03.jpg

ISPOR Good Practices Report Offers Guidance for Using Real-World Data From EHRs in Health Technology Assessments

ISPOR鈥擳he Professional Society for Health Economics and Outcomes Research announced today the publication of an ISPOR Good Practices Report that proposes a framework for assessing the suitability of electronic health records data for use in health...
17-Jun-2024 4:05 AM EDT Add to Favorites


See All News

Our Experts on News

Our experts are coming soon...

Our YouTube Videos
View All >

About

ISPOR鈥擳he Professional Society for Health Economics and Outcomes Research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field.

ISPOR鈥檚 community of 14,000 individual and chapter members from more than 100 countries includes a wide variety of healthcare stakeholders, including researchers and academicians, assessors and regulators, payers and policy makers, the life sciences industry, healthcare providers, and patient engagement organizations. The Society鈥檚 leadership has served as an unbiased resource and catalyst for innovation in the field for more than 25 years.

Twitter

Facebook

close
0.28529